Article Sidebar

PDF
Date Published: 13/11/2022
Abstract Views: 175
Views PDF: 163
DOI: https://doi.org/10.51298/vmj.v519i2.3624
Issue
Vol. 519 No. 2 (2022)
Section
Các bài báo
How to Cite
Đắc Đông, P. ., & Lê Thắng, P. . (2022). CLINICAL, SUBCLINICAL FEATURES AND RESULTS OF SURGERY FOR THE TREATMENT OF LUNG CANCER PATIENTS AT HANOI ONCOLOGY HOSPITAL. Vietnam Medical Journal, 519(2). https://doi.org/10.51298/vmj.v519i2.3624

CLINICAL, SUBCLINICAL FEATURES AND RESULTS OF SURGERY FOR THE TREATMENT OF LUNG CANCER PATIENTS AT HANOI ONCOLOGY HOSPITAL

Phạm Đắc Đông1,, Phan Lê Thắng2
1 Hanoi Medical University
2 Hanoi Oncology Hospital

Main Article Content

Abstract

Objective: Describing several clinical and subclinical features and assessing the results of surgery for the treatment of non-small cell lung cancer patients at Hanoi Oncology Hospital from 05/2019 to 04/2022. Patients and method: Retrospective and prospective analysis of 59 patients diagnosed of staged I-IIIA non-small cell lung carcinoma and treated with surgery at Hanoi Oncology Hospital from 05/2019 to 04/2022. Results: The mean age was 58.90 ± 9.32 years old (range, 35 - 72), male patients accounted for 49.2%. Patients presented with chest pain for 45.7%, then 40.6% of cases had cough. Rate of anemia was 8.5%. Most of patients presented with a right lung cancer (61%). Most of patients diagnosed of stage Ib (37.3%), then stage Iib (23.7%). Rate of open surgery was 55.9% of cases. There was a report of one patient experienced of rupture of azygos vein during operation. There was 6.8% of patients presented with prolong pneumothorax and 3.4% of pneumotitis during post-operation. Conclusion: Lung cancer patients presented with the common symptoms of chest pain and cough, and the surgery of staged I-IIIA non-small cell lung cancer had a good result with a low complication.

Article Details

Keywords

lung cancer, stage I-IIIA, surgery, Hanoi Oncology Hospital

References

1. Siegel RL, Miller KD, Jemal A (2015), Cancer statistics, CA Cancer JClin. Jan-Feb;65(1):5-29. 2015.
2. John K. Field (2012). Perspective: The screening imperative. Nature, 513-516.
3. American Cancer Society (2007). Global cancer facts & figures 2007. CA Cancer J Clin, 7, pp. 13-56.
4. Douillard J.-Y., Rosell R., De Lena M. và cộng sự. (2006). Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol, 7(9), 719–727.
5. Winton T., Livingston R., Johnson D. và cộng sự. (2005). Vinorelbine plus cisplatin vs. observation in resected non–small-cell lung cancer. N Engl J Med, 352(25), 2589–2597.
6. Boffa D. J. and Allen M. S. (2008), "Data from The Society of Thoracic Surgeons General Thoracic Surgery database: The surgical management of primary lung tumors", The Journal of Thoracic and Cardiovascular Surgery. 135(2), pp. 247 - 254.
7. Yamamoto K., Ohsumi A., and Kojima F. (2010), "Long - Term Survival After Video - Assisted Thoracic Surgery Lobectomy for Primary Lung Cancer", Ann Thorac Surg. 89, pp. 353 - 359.
8. Port J. L., Mirza F. M., and Lee P. C. (2011), "Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery", Ann Thorac Surg, pp. 1006-1082.
9. Nomori H., Ohtsuka T., and Hirotoshi H. (2003), "Thoracoscopic Lobectomy for Lung Cancer With a Largely Fused Fissure", Chest. 123, pp. 619-622.
10. Elsayed H., McShane J., and Shackcloth M. (2012), "Air leaks following pulmonary resection for lung cancer: is it a patient or surgeon related problem?", Ann R Coll Surg Engl. 94, pp. 422 - 427.